Advertisement

Topics

Prostate Oncology Specialists,Inc. Company Profile

09:40 EDT 20th June 2018 | BioPortfolio

Prostate Oncology Specialists is a medical group exclusively devoted to caring for men with prostate cancer. We have vast experience diagnosing and treating prostate cancer because 100% of our time is focused on managing men with this disease. Our physicians are board certified in both medical oncology and internal medicine and have made significant contributions to the scientific advancement in this field

Location

4676 Admiralty Way, Suite 101
Marina del Rey
California
90292
United States of America

Contact

Phone: 310.827.7707
Fax: 310.574.4002
Email: linda@prostateoncology.com


News Articles [1487 Associated News Articles listed on BioPortfolio]

Rutgers researcher receives $1 million grant for international prostate cancer study

A $1 million grant from Gateway for Cancer Research will help Rutgers Cancer Institute of New Jersey Urologic Oncology Chief Isaac Yi Kim, MD, PhD, MBA evaluate the impact of surgically removing the p...

Higher-dose RT does not improve survival but reduces recurrence risk for prostate cancer patients

Results of a recent NRG Oncology study, NRG Oncology/RTOG 0126, show that high-dose radiotherapy did not improve survival for men with intermediate-risk prostate cancer but did improve biochemical con...

Sleep Specialists and Non-Sleep Specialists Alike Can Provide Effective Apnea Care

Non-sleep specialists can diagnose and manage obstructive sleep apnea as well as specialists can, suggests a review in the Annals of Internal Medicine. However...

Could Prostate Cancer Be Treated with Aromatherapy in the Future?

Treating prostate cancer could one day be as noninvasive as inhaling certain scented compounds. The idea may not be as far-fetched as it sounds given that new research from investigators at Duke Unive...

Rob Lowe Hosts a New "On Demand" Episode on Prostate Surgery

A new medical segment of the series will delve into prostate cancer and surgery. (PRWEB) April 25, 2018 Prostate cancer is one of the most common forms of cancer among men. The disease is the third l...

Genetic Mutations and Prostate Cancer: Screening Recommendations

In light of recently published data, Dr David Graham suggests potential approaches to prostate cancer screening that incorporate genetic test results. Medscape Oncology

ASCO GU 2018: Opening new therapeutic avenues in metastatic prostate cancer

Selected by the American Society of Clinical Oncology (ASCO) to first outing during its Genitourinary Cancers Symposium, Joaquin Mateo, principal investigator of VHIO's recently created Prostate Cance...

His Prostate Cancer Becomes Her Struggle, Too

FRIDAY, March 23, 2018 -- Difficulties tied to prostate cancer may not be limited to men. Many wives of men with advanced prostate cancer say their husband's illness has harmed their own health, a new...

PubMed Articles [2506 Associated PubMed Articles listed on BioPortfolio]

Radioligand therapy of metastatic castration-resistant prostate cancer: current approaches.

Prostate Cancer is the forth most common type of cancer. Prostate-specific membrane antigen (PSMA) is anchored in the cell membrane of prostate epithelial cells. PSMA is highly expressed on prostate e...

Development of quality indicators to monitor radiotherapy care for men with prostate cancer: A modified Delphi method.

Quality indicators (QIs) have been developed for many aspects of prostate cancer care, but are under-developed with regard to radiotherapy treatment. We aimed to develop a valid, relevant and feasible...

Patient reported outcomes in NRG Oncology RTOG 0938, evaluating two ultrahypofractionated regimens for prostate cancer.

There is considerable interest in very short (ultrahypofractionated) radiotherapy regimens to treat prostate cancer based on potential radiobiological advantages, patient convenience and resource allo...

Concordance of Non-Low-Risk Disease Among Pairs of Brothers With Prostate Cancer.

Purpose Prostate cancer among first-degree relatives is a strong risk factor for diagnosis of prostate cancer, and the contribution of heritable factors in prostate cancer etiology is high. We investi...

Physical activity in relation to risk of prostate cancer: a systematic review and meta-analysis.

Prostate cancer (PCa) is one of the most common cancers among men, yet little is known about its modifiable risk and protective factors. This study aims to quantitatively summarize observational studi...

Clinical Trials [2874 Associated Clinical Trials listed on BioPortfolio]

Stereotactic Prostate Adaptive Radiotherapy Utilising Kilovoltage Intrafraction Monitoring

The SPARK trial is testing the use of Kilovoltage Intrafraction Monitoring in prostate cancer patients being treated with Stereotactic Prostate Adaptive Radiotherapy. The researchers expe...

Collection of Blood From Patients With Prostate Cancer

Background: - It is not fully understood why prostate cancer in some men becomes androgen-independent (no longer responds to anti-androgen medication), but genetics likely plays a...

PALLiON - PALLiative Care In ONcology

A major concern in today's oncology is the complexity of treatment that increases costs. A main contributor is the increasing use of chemo- and radiotherapy during end of life (EoL: the la...

Hypofractionated SBRT For Prostate Cancer

The purpose of this study is to determine, in both low-risk and intermediate-risk cohorts, the rates of acute and late grade 3 or higher gastrointestinal and genitourinary toxicity observe...

Trimodal (18)F-choline-PET/mpMRI/TRUS Targeted Prostate Biopsies

Prostate cancer is the first cancer in humans (25%). The most widely used tracer in oncology, the 18-Fluoro DeoxyGlucose does not allow the study of prostatic neoplasia. On the other hand,...

Companies [1327 Associated Companies listed on BioPortfolio]

Prostate Oncology Specialists,Inc.

Prostate Oncology Specialists is a medical group exclusively devoted to caring for men with prostate cancer. We have vast experience diagnosing and treating prostate cancer because 100% of our time is...

Prostate Oncology Specialists, Inc.

According to the American Cancer Society, prostate cancer is the most common non-skin cancer in the United States and the third most common cancer worldwide. More than two million men in the United St...

Texas Oncology

Texas Oncology delivers high-quality cancer care with leading-edge technology and advanced treatment and therapy options available to help patients achieve “More breakthrough...

Minomic International Ltd

Minomic International Ltd is an Australian immuno-oncology company specialising in therapeutics and diagnostics for prostate cancer and other cancers. Minomic has developed the in...

Prostate Cancer Foundation

The Prostate Cancer Foundation (PCF) is the world’s largest philanthropic source of support for accelerating the world’s most promising research for discovering better t...

More Information about "Prostate Oncology Specialists,Inc." on BioPortfolio

We have published hundreds of Prostate Oncology Specialists,Inc. news stories on BioPortfolio along with dozens of Prostate Oncology Specialists,Inc. Clinical Trials and PubMed Articles about Prostate Oncology Specialists,Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Prostate Oncology Specialists,Inc. Companies in our database. You can also find out about relevant Prostate Oncology Specialists,Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record